全血与Hextend:现代战术战伤救治现场复苏的两端及多功能复苏液开发的起点
该研究在非人灵长类多发伤(股骨骨折、15cm剖腹切口、控制性失血至平均动脉压20mmHg)失血性休克模型中,比较战术战伤救治指南推荐的两端——Hextend与全血——作为预hospital复苏手段的效果。动物随机接受全血或Hextend,90分钟后实施确定性手术和平衡血性损伤控制复苏,480分钟处死。结果显示两组生存率(83% vs 100%,p=0.3)、组织灌注(EtCO2、StO2)及复苏终点(碱缺失、乳酸、pH)均无显著差异;全血组较Hextend组凝血形成时间、最大血凝块强度和α角恢复正常更早。作者认为,未来包含无血、胶体渗透压、非携氧组分及合成凝血因子和纤维蛋白原组分的多功能复苏液可能等效于全血。
要点
- 在非人灵长类多发伤失血性休克模型中,Hextend与全血预hospital复苏的生存率无显著差异(83% vs 100%,p=0.3)。
- 两组组织灌注(EtCO2、StO2)和复苏终点(碱缺失、乳酸、pH)均无显著差异。
- 全血组较Hextend组凝血形成时间、最大血凝块强度和α角恢复正常显著更早。
- 作者认为,未来含无血胶体渗透压非携氧组分及合成凝血因子和纤维蛋白原组分的多功能复苏液可能等效于全血。
适用人群与场景
- 非人灵长类动物模型,采用多发伤模型:股骨骨折、15cm剖腹切口软组织伤、控制性失血至平均动脉压20mmHg进入休克期。
- 模拟预hospital场景,T=0分钟给予预hospital干预,T=90分钟实施确定性手术和平衡血性损伤控制复苏,T=480分钟处死动物。
处置流程与药物剂量
- 动物随机接受预hospital干预:全血或Hextend,于T=0分钟给予。
- T=90分钟实施确定性手术干预和平衡血性损伤控制复苏。
- 所有动物于T=480分钟处死。
研究设计与关键结果
- 研究类型:转化动物模型(非人灵长类多发伤失血性休克模型)。
- 干预与对照:全血 vs Hextend预hospital复苏,T=90分钟起允许确定性手术和平衡血性损伤控制复苏。
- 主要终点:生存率全血组83% vs Hextend组100%,p=0.3,无显著差异。
- 组织灌注(EtCO2、StO2)和复苏终点(碱缺失、乳酸、pH)两组无显著差异。
- 全血组较Hextend组凝血形成时间、最大血凝块强度和α角恢复正常显著更早。
证据类型、等级与局限
- 证据类型:转化动物模型(非人灵长类)。
- 证据等级:原文标注LEVEL OF EVIDENCE: N/A(研究类型:转化动物模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,未来包含无血、胶体渗透压、非携氧组分以促进血管内容量扩张,以及含合成凝血因子和纤维蛋白原组分以阻止凝血病的多功能复苏液,可能等效于全血。
指南或共识出处
- 战术战伤救治指南(Tactical Combat Casualty Care Guidelines)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hemorrhage is the leading cause of preventable death in traumatically injured civilian and military populations. Prehospital resuscitation largely relies on crystalloid and colloid intravascular expansion, as whole blood and component blood therapy are logistically arduous. In this experiment, we evaluated the bookends of Tactical Combat Casualty Care Guidelines recommendations of prehospital resuscitation with Hextend and whole blood in a controlled hemorrhagic shock model within non-human primates, as means of a multifunctional resuscitative fluid development.
METHODS: In the nonhuman primate, a multiple injuries model was used, consisting of a musculoskeletal injury (femur fracture), soft tissue injury (15-cm laparotomy), and controlled hemorrhage to a mean arterial pressure of 20 mm Hg, demarcating the beginning of the shock period. Animals were randomized to prehospital interventions of whole blood or Hextend at T = 0 minutes, and at T = 90 minutes definitive surgical interventions and balanced sanguineous damage control resuscitation could be implemented. All animals were euthanized at T = 480 minutes. Data are expressed as mean ± SEM; significance, p < 0.05.
RESULTS: No significant differences in survival (83% vs. 100%; p = 0.3), tissue perfusion (EtCO2 and StO2) or endpoints of resuscitation (base deficit, lactate, pH) between Hextend and whole blood were identified. Second, whole blood compared with Hextend demonstrated significantly earlier normalization of clot formation time, maximal clot firmness, and α angle.
CONCLUSION: A future multifunctional resuscitative fluid including an asanguineous, oncotic, non-oxygen-carrying component to facilitate intravascular volume expansion, and a component with synthetic coagulation factors and fibrinogen to deter coagulopathy may show equivalence to whole blood.
LEVEL OF EVIDENCE: N/A: Study type: translational animal model.
参考来源
- Sheppard FR, Mitchell TA, Macko AR, et al. Whole blood and Hextend: Bookends of modern tactical combat casualty care field resuscitation and starting point for multifunctional resuscitation fluid development. J Trauma Acute Care Surg. 2018. PMID: 29261592. doi:10.1097/TA.0000000000001772
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。